Who is sponsoring NCT04831892?

NCT04831892 is sponsored by Integrative Skin Science and Research.

What condition does NCT04831892 study?

NCT04831892 studies Atopic Dermatitis.

Is NCT04831892 still recruiting?

NCT04831892 is currently completed. Last updated 9 November 2022.

Last reviewed 2022-11-09 · How we verify

NCT04831892

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Isosorbide Diesters Based Moisturizer on Skin Health

Completed NA Last updated 9 November 2022

What this trial tests

NA trial testing Moisturizer Containing Isosorbide Diesters and Colloidal Oatmeal in Atopic Dermatitis in 34 participants. Completed in 30 April 2022.

Timeline

12 April 2021

Primary endpoint
30 April 2022

30 April 2022

Quick facts

Lead sponsor	Integrative Skin Science and Research
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	34
Start date	12 April 2021
Primary completion	30 April 2022
Estimated completion	30 April 2022
Sites	1 location across United States

Drugs / interventions tested

Moisturizer Containing Isosorbide Diesters and Colloidal Oatmeal
Moisturizer containing Colloidal Oatmeal only

Conditions studied

Atopic Dermatitis — all drugs for Atopic Dermatitis →

Sponsor

Integrative Skin Science and Research

Who can join

18 and older, any sex, with Atopic Dermatitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall objective of this study is to assess how a natural ingredient, isosorbide diesters (IDEAS), works in association with colloidal oatmeal for eczema.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Clinical Measurement of Transepidermal Water Loss.
Kundu D, Jayaraman A, Sen CK. · · 2026 · cited 4× · PMID 40476522 · DOI 10.1089/wound.2024.0148
Prospective Randomized Double-Blind Vehicle-Controlled Study of Topical Coconut and Sunflower Seed Oil-Derived Isosorbide Diesters on Atopic Dermatitis.
Nadora D, Burney W, Chaudhuri RK, Galati A, et al · · 2024 · cited 4× · PMID 38394048 · DOI 10.1089/derm.2023.0329

Verify or expand the search:

Other recruiting trials for Atopic Dermatitis

Currently open trials in the same condition.

NCT07262983 — Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopi · Phase 1 · recruiting
NCT07445919 — A Clinical Study to Evaluate SM17 for Atopic Dermatitis · Phase 2 · recruiting
NCT07488065 — A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants · Phase 1 · recruiting
NCT07467564 — The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopic Dermatit · recruiting
NCT07358156 — A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and E · Phase 1 · recruiting

Other Integrative Skin Science and Research trials

Trials by the same sponsor.

NCT06571721 — The Effects of Topical Almond Oil and Tretinoin on Facial Wrinkles · NA · recruiting
NCT06146166 — The Effects of an Oral Hair Supplement on Hair Density, Growth, and Microbiome · NA · active not recruiting
NCT06146140 — Effects of an Oral Herbal Supplement on Skin Aging, Hydration, and Elasticity · NA · unknown
NCT06072066 — Effects of Oral Supplement Containing L-Histidine and Antioxidants on the Skin Barrier Function and Systemic Inflammatio · NA · recruiting
NCT06142487 — Assessment of the Effects of Silk Pillowcases on Acne Prone Skin · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04831892 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Integrative Skin Science and Research
Last refreshed: 9 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04831892.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing